US HB7113 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on June 4 2020 - 25% progression, died in committee
Action: 2020-06-04 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 4 2020 - 25% progression, died in committee
Action: 2020-06-04 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Public Health Service Act to establish an Emergency Office of Manufacturing for Public Health, and for other purposes.
Title
COVID–19 Emergency Manufacturing Act of 2020
Sponsors
Rep. Janice Schakowsky [D-IL] | Rep. Brad Sherman [D-CA] |
History
Date | Chamber | Action |
---|---|---|
2020-06-04 | House | Referred to the House Committee on Energy and Commerce. |
2020-06-04 | House | Introduced in House |
Same As/Similar To
SB3847 (Related) 2020-06-01 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Blood and blood diseases
Cardiovascular and respiratory health
Congressional oversight
Corporate finance and management
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Executive agency funding and structure
Federal officials
Genetics
Government ethics and transparency, public corruption
Government information and archives
Government studies and investigations
Health
Health personnel
Health technology, devices, supplies
Immunology and vaccination
Indian social and development programs
Infectious and parasitic diseases
Inflation and prices
Licensing and registrations
Manufacturing
Marketing and advertising
Medical tests and diagnostic methods
Minority health
Prescription drugs
Public contracts and procurement
Public participation and lobbying
State and local government operations
Strategic materials and reserves
Worker safety and health
Cardiovascular and respiratory health
Congressional oversight
Corporate finance and management
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Executive agency funding and structure
Federal officials
Genetics
Government ethics and transparency, public corruption
Government information and archives
Government studies and investigations
Health
Health personnel
Health technology, devices, supplies
Immunology and vaccination
Indian social and development programs
Infectious and parasitic diseases
Inflation and prices
Licensing and registrations
Manufacturing
Marketing and advertising
Medical tests and diagnostic methods
Minority health
Prescription drugs
Public contracts and procurement
Public participation and lobbying
State and local government operations
Strategic materials and reserves
Worker safety and health
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/7113/all-info |
Text | https://www.congress.gov/116/bills/hr7113/BILLS-116hr7113ih.pdf |